Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

CYBERSECURITY FOR INDUSTRIAL NETWORKS AND CONTROL SYSTEMS Secure-NOK® is a technology company providing cybersecurity solutions for monitoring industrial networks (OT), and for detecting vulnerable areas. The company has vast experience and recognized technology, and has participated in several research projects with outstanding results. The technology (SNOK) can detect any abnormal event in a network and prevent important infrastructure from experiencing downtime due to malicious attack. Today, most industries are digitized, and thus more exposed to attacks from the outside. With technology from Secure-NOK, such attacks will be detected early, and thus avoid damage and downtime. Secure-NOK has developed patented sensors which are installed in a OT network, and which capture and report any abnormal traffic. The company has sensors for both networks, end-stations and PLC systems.

Together with four Norwegian hospitals, we have developed the next generation hospital bed. A bed that prevents pressure ulcers, fall and reduce nurse load by removing heavy lifting and monitors the patients state, non intrusive. Have recieved contracts in Toronto that accelerates development, and secures uptake and sales if the clinical trial goes as planned.

Our vision is to design and operate a “Green High-Security Hyperscale Datacenter” with the lowest PUE (Power Usage Efficiency) in the world.Think BigStart SmallMove Fast. Development of Green High-Security Datacenters, embarking upon groundbreaking environmental and state-of-the-art power usage efficiency technology.

VENTURE FACTORYVenture Factory was founded in the fall of 2012 in Oslo, Norway with a straightforward goal: turning ideas into business. Our core competence is e-commerce, technology, and performance marketing. We use our skills to start new companies together with strategic partners, other entrepreneurs, or within our own organization. Since then we’ve involved ourselves in a range of ideas. Some have blossomed and turned into prosperous businesses, while others have been challenging and ultimately put to rest. We believe our understanding of technology and online marketing combined with a unique domain insight is the recipe for success and therefore we partner up with entrepreneurs or larger corporations to pursue new business opportunities. Our portfolio consists of a mix of businesses. Some are consultancies where external clients benefit from our competence and others are tech or e-commerce ventures that we have started alone or together with partners. Do you have a great idea you want to discuss with us? Please email us at contact@venturefactory.noVenture Factory offices are located centrally in Oslo and our development team is located in Odesa, Ukraine. We are always on the lookout for great talent both in Odessa and Oslo, so email us at contact@venturefactory.no if you think you are a good match.

Defigo is the only intelligent building system designed for apartment buildings. We plug into the building infrastructure, control door locks, elevators, lights, ventilation, and fire alarms, and provide users with one common user interface. We offer a wide range of intelligent and innovative services, provided by ourselves or through partners, that increase safety and convenience and reduce cost and hassle.

I 2015 begynte Cutters sin reise med mål om å kunne tilby alle hårklipper av høy kvalitet til en fornuftig pris. I dag er Cutters Norges mest innovative og nytenkende frisørkonsept og har for dette blant annet mottat støtte fra Innovasjon Norge to ganger. Frisørsalongene våre er av de mest besøkte i hele landet og vi får mye oppmerksomhet fra media, kunder og konkurrenter. Hos Cutters gjør vi ikke ting slik det alltid er blitt gjort. Det farligste uttrykket vi vet om er «vi har alltid gjort det på denne måten». Vi ser etter mennesker som tør å tenke annerledes og som våger å bryte regler og normer. Les mer på: Nettside: www.cutters.no Facebook: www.facebook.com/cuttersglobal Instagram: @cuttersglobal LinkedIn: www.linkedin.com/company/cuttersglobal

For SMB, who wants to create a carbon inventory and budget, the Scope321 platform is a carbon reporting tool, that is easy to use, automates data gathering and integrates with suppliers. Unlike current carbon reporting systems, our product will translate your accounting data into carbon data, so you don't have to track it in other systems or logs.

We believe the transition from offline to online is ongoing, and gaining momentum every day. Our platform is tuned for rapid growth, expansion, and easy add-ons for new concepts. One of four founders contributing to scaling from zero to ~100 MNOK revenue in three years. Current position CEO, managing daily activities and future expansion. We are focusing on growth and believe this is just the beginning. Come join the fun!

FeltGIS AS er et teknologiselskap grunnlagt i 2016 og som har spesialisert seg på M2M kommunikasjon og digitale kart. Med et kjerneteam på 7 personer utgjør FeltGIS en unik kombinasjon av spesialisering innenfor GIS-teknologi og mobilkommunikasjon, med lang erfaring fra -og kunnskap om moderne skogsdrift. Selskapet utvikler en digital samhandlingsplattform for planlegging og gjennomføring av hogst, og som digitaliserer rapportering av data for kommersiell anvendelse og ift. miljø- og kvalitetssertifisering. Selskapet har betydelige aktører i bransjen på sin kundeliste. Med FeltGIS sine kart- og datadrevet løsninger får aktørene, private som offentlige, unike muligheter til å optimalisere skogens sirkulære forretningspotensiale og bærekraftige natur ved å dele, samarbeide, og dra nytte av skogkultur, miljø- og produksjonsdata, fra planting til hogst og transport, og videre til resten av næringen.

Every year 282 million metric tonnes of plastic waste is produced worldwide, yet only 15% of this is recycled. This needs to change. AION’s purpose is to industrially scale a circular plastic economy. We make circularity happen at an industrial scale by working with our customers to identify opportunities to shift from linear to circular and grow their degree of circularity within plastic. Together with our partners we orchestrate a tailored, traceable and circular value chain for specific use cases. Our team of material, regulatory, logistics and business development experts work with companies to make sure the products and processes fit their existing operations, meet quality requirements and importantly have a tangible impact towards reducing their use of virgin plastic, reducing their CO2 footprint, and avoiding a generation of plastic waste.

In tight collaboration with medical experts, we at Connect the Dots design and develop a virtual world where medical personnel can perform extensive medical procedural training in a safe environment without risking patient lives. Our goal is to increase the efficiency, productivity, and availability of practical medical procedure training.

Hybel is bringing reputability and automation to the private residential tenancy management market by providing a marketplace to match prospective tenants with landlords, as well as automating the day-to-day tasks of property management. We think there are too many bad-actors within the private residential rental market and are providing a platform where tenants & landlords can have successful tenancies and facilitate understanding their rights, responsibilities and obligations.

Smartsky AS is a young, innovative and exciting tech start-up invested in the technological development of smart cities and communities. Since our establishment in 2020, we have achieved great results in a short time, securing various projects and funding. To date, we are 8 team members working in close collaboration with our Norwegian and Finnish tech partners actively developing tech solutions for smart cities.